RPS19 and Diamond-Blackfan anemia: A drug screen was conducted on induced pluripotent stem cells from DBA patients (reprogrammed fibroblasts from patients with inactivating RPS19 and RPL5 mutations) and SMER28 was identified as a compound that stimulated erythropoiesis [47].